Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia

Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia

Abstract Attention‐deficit hyperactivity disorder (ADHD) is characterized by persistent symptoms of inattention, hyperactivity, and impulsivity. Both, stimulant and nonstimulant medications have been approved for the treatment of this disorder. Several Western guidelines recommend the use of prescri...

Full description

Bibliographic Details
Main Authors: Kentaro Kawabe, Fumie Horiuchi, Yu Matsumoto, Saori Inoue, Maya Okazawa, Rie Hosokawa, Kiwamu Nakachi, Junya Soga, Shu‐Ichi Ueno
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Neuropsychopharmacology Reports
Subjects:
ADHD
guanfacine
guideline
lisdexamfetamine
methylphenidates
Online Access:https://doi.org/10.1002/npr2.12381

Internet

https://doi.org/10.1002/npr2.12381

Similar Items